IGF1R-Targeted Therapy and Its Enhancement of Doxorubicin Chemosensitivity in Human Osteosarcoma Cell Lines

Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M Transition

(2010) Oleg Timofeev et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Multiple pathways are involved in drug resistance to doxorubicin in an osteosarcoma cell line

(2009) Thangarajan Rajkumar et al.   ANTI-CANCER DRUGS

Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines

(2009) Kiyonori Kai et al.   CANCER LETTERS

The Type 1 Insulin-Like Growth Factor Receptor Pathway

(2008) M. M. Chitnis et al.   CLINICAL CANCER RESEARCH

Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro

(2008) Patrick J. Messerschmitt et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer

(2008) Keren Paz et al.   COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING

Targeting insulin and insulin-like growth factor signalling in oncology

(2008) Michael Pollak   CURRENT OPINION IN PHARMACOLOGY

The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance

(2008) Angelo et al.   Frontiers in Bioscience-Landmark

Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines

(2008) Claudia M. Hattinger et al.   GENES CHROMOSOMES & CANCER

IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons

(2008) S. John Weroha et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA